sizeable interest has been gained by osimertinib, which is a drug extensively used in the treatment of cancer, for its potential benefits in cost efficiency.This article investigates the concept of cost efficiency through osimertinib and investigates various factors that lead to these savings.Healthcare providers, patients, and insurance companies can take sound judgments to enhance the utilization of osimertinib by comprehending its cost-influencing factors and identifying possible ways to save money.osimertinib, a precision treatment, prevents the activity of the EGFR alteration, which is a prevalent genetic change in cancer.Although scientifically established…
